However, some individuals may experience initial gastrointestinal side effects when starting berberine
If you'd rather watch and learn, here's our video that recaps the main content of this article
The regulatory reality: what you need to know about compounded GLP-1 medications This section is not optional reading
Br J Pharmacol 179(4):557570 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018a) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
If reactions persist for more than 48 hours, document them with photos to share with your healthcare provider